Real-world use of insulin degludec/liraglutide (IDegLira) significantly improves glycaemic control in patients with Type 2 diabetes

被引：0
|
作者：
Feher, M. [1 ]
Price, H. [2 ]
Schultes, B. [3 ]
Prager, R. [4 ]
Phan, T. M. [5 ]
Thorsted, B. L. [6 ]
Bluher, M. [7 ]
机构：
[1] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[2] Southern Hlth NHS Fdn Trust, Bournemouth, Dorset, England
[3] ESwiss Med & Surg Ctr, Internal Med, St Gallen, Switzerland
[4] Hietzing Hosp, Dept Metab Disorders & Nephrol, Vienna, Austria
[5] Novo Nordisk Reg Europe Pharmaceut AS, Copenhagen, Denmark
[6] Novo Nordisk AS, Global Market Access, Soborg, Denmark
[7] Univ Leipzig, Dept Med, Leipzig, Germany
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P391
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [31] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [32] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Junko Oya
    Tomoko Nakagami
    Yukiko Hasegawa
    Yuichiro Kondo
    Aki Katamine
    Mika Shimizu
    Ryo Kubota
    Rika Suda
    Tetsuya Babazono
    Diabetology International, 2024, 15 : 237 - 243
  • [33] Improved postprandial glycaemic control in Type 2 diabetes with a combination of insulin degludec and liraglutide: results from a meal test
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L.
    Bode, B. W.
    DIABETIC MEDICINE, 2014, 31 : 61 - 61
  • [34] Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia
    Mussa H. AlMalki
    Hossam Aldesokey
    Dania Alkhafaji
    Abdulrahman Alsheikh
    Uffe Christian Braae
    Lars Lang Lehrskov
    Waleed Magawry
    Moataz Yahia
    Ahmed Haroun
    Advances in Therapy, 2023, 40 : 568 - 584
  • [35] Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidence
    Mezquita Raya, Pedro
    Ampudia Blasco, Francisco Javier
    Hunt, Barnaby
    Martin, Virginia
    Larsen Thorsted, Brian
    Basse, Amaury
    Price, Hermione
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1349 - 1356
  • [36] VIEW-Iran: A real-world study of liraglutide effectiveness on glycaemic control in people with type 2 diabetes mellitus
    Khamseh, M. E.
    Hosseinpanah, F.
    Malek, M.
    Damavandi, M. H.
    Thamattoor, U. K.
    Kaltoft, M. S.
    Esteghamati, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [37] A novel fixed-ratio combination of insulin degludec and liraglutide improves postprandial glycaemic control in patients with type 2 diabetes: results from a standardised meal test
    Holst, J. J.
    Buse, J.
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L. H.
    Bode, B. W.
    DIABETOLOGIA, 2013, 56 : S359 - S359
  • [38] An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin
    Evans, Marc
    Billings, Liana K.
    Hakan-Bloch, Jonas
    Slothuus, Ulla
    Abrahamsen, Trine J.
    Andersen, Andreas
    Jansen, Jeroen P.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (04) : 340 - 347
  • [39] Switching to Insulin Degludec Improves Glycemic Control in Patients with T2DM in a Real-World Setting
    Schultes, Bernd
    Tentolouris, Nikolaos
    Knudsen, Soren T.
    Lapolla, Annunziata
    Eidenmueller, Markus
    Prager, Rudolf
    Phan, Tra-Mi
    Wolden, Michael L.
    Siegmund, Thorsten
    DIABETES, 2017, 66 : A266 - A266
  • [40] Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
    Minze, Molly G.
    Chastain, Lisa M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 471 - 478
12345